CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
Clinical trial NCT06479356 · RECRUITING
Trial details
- NCT number
- NCT06479356
- Sponsor
- Shanghai Ming Ju Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-15
- Primary completion
- 2025-04-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.